UB-221
UBP-A107-IgE
Phase 1 mab completed
Quick answer
UB-221 for Urticaria Chronic is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Urticaria Chronic
- Phase
- Phase 1
- Modality
- mab
- Status
- completed